Rectal Cancer
Rectal cancer Definition The rectum is the portion of the large bowel that lies in the pelvis, terminating at the anus. Cancer of the rectum is the disease characterized by the development of malignant cells in the lining or epithelium of the rectum. Malignant cells have changed such that they lose
Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center
Introduction Rectal cancer is one of the most frequently diagnosed GI cancers having a high disease related mortality in the western part of the world, although in eastern regions it is one of the low incidence cancers not ranking among the first ten.[12345] Adenocarcinoma is the most common type
T4 Rectal Cancer: Analysis of Patient Outcome After Surgical Excision/DISCUSSION
Locally advanced rectal cancer dictates a major surgical undertaking, which includes en bloc resection of the rectum and all involved organs. The aim of this study was to evaluate patient outcome and compare multimodality treatment options after various surgical approaches from one institution for
Two-Stage Surgical Treatment of Unresectable Obstructive Rectal Cancer with Synchronous Hepatic Metastases
Unresectable obstructing rectal cancer with synchronous hepatic metastases is usually a fatal disease. This prospective study was scheduled to treat this difficult condition using a multimodal curative strategy combined with a two-stage surgical treatment. Patients with T4N2 or N3M1 rectal cancer
Local treatment of rectal cancer.
Approximately 37,000 new cases of rectal cancer are diagnosed each year in the United States.[1] The overall survival rate for individuals with rectal cancer is approximately 50 percent.[2] Tumors of the distal rectum have classically been treated by abdominoperineal resection, which is associated
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
Colorectal cancer is one of our most common cancer types, and rectal cancer constitutes one third of the carcinomas within the large bowel. About 40% of colorectal cancer patients who have undergone curative surgery will develop local, regional, or distant tumor recurrences. Prognostic markers are
Treatment Disparities in Hispanic Rectal Cancer Patients: A SEER Database Study
Although Hispanics demonstrate a low overall incidence of rectal cancer, mortality rates have not decreased relative to non-Hispanic whites. To determine if this was in part due to racial disparities in care, we compared rates of neoadjuvant therapy and sphincter-preserving surgery between
Cutaneous Metastases in Patients with Rectal Cancer: A Report of Six Cases
Cutaneous metastases from rectal cancer are rare manifestations of disseminated disease and uniformly represent dismal survival. A retrospective review of six patients with rectal cancer metastatic to the dermis was performed. The diagnosis of rectal cancer was made concurrently with the diagnosis
How often does rectal bleeding indicate colorectal cancer?(Disease/Disorder overview)
Rectal bleeding is a relatively common symptom encountered in primary care. Although the risk of colorectal cancer is believed to be low, this rarely has been studied in patients presenting to primary care physicians. Four studies in European countries reported cancer rates of 2.4 to 7.0 percent.
Results of long-term follow-up for transanal excision for rectal cancer
Low anterior resection and abdominoperineal resection are the surgical techniques used most frequently in the treatment of rectal cancer. It is our hypothesis that selected patients with early T stage, well or moderate grade of differentiation, and small tumor size are good candidates for transanal
